{"id":"W4312064913","doi":"","title":"Olumiant<sup>®</sup> (Baricitinib)-A Newly Approved Janus Kinase Inhibitor for the Treatment of Alopecia Areata.","year":2022,"lang":"en","type":"article","venue":"PubMed","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Alopecia areata; Dermatology; Placebo; Adverse effect; Rheumatoid arthritis; Janus kinase; Janus kinase inhibitor; Tofacitinib; Hair loss; Clinical trial; Regimen; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002483205,0.0005145751,0.0006081884,0.0008412817,0.0003848451,0.0009501613,0.0006742583,0.000675733,0.02129197],"category_scores_gemma":[0.0002937944,0.0002246878,0.0006341122,0.0007050564,0.0002285147,0.0006355034,0.0005723886,0.001417388,0.01018363],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005929947,"about_ca_system_score_gemma":0.000937274,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001653567,"about_ca_topic_score_gemma":0.00803984,"domain_scores_codex":[0.9998419,0.00001902319,0.00001843938,0.00001737965,0.00006137633,0.0000418196],"domain_scores_gemma":[0.9998579,0.00001224595,0.00003977629,0.000005806398,0.00003215937,0.00005197453],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004471526,0.0007534885,0.001274357,0.003178292,0.0002747109,0.001590476,0.00004475254,0.0002347987,0.05015319,0.002775599,0.222329,0.7129197],"study_design_scores_gemma":[0.007526794,0.004427091,0.01335575,0.001062775,0.0005323903,0.01106253,0.0001065445,0.0008353347,0.03015606,0.001159185,0.9296682,0.0001073581],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.0858329,0.6609761,0.003109117,0.02038434,0.01534071,0.001198901,0.01331722,0.002037018,0.1978037],"genre_scores_gemma":[0.3273021,0.4142342,0.008046995,0.01743893,0.005915385,0.0007621529,0.03064775,0.0002172467,0.1954353],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.02129197,"threshold_uncertainty_score":0.07122874,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04840604476283174,"score_gpt":0.2761010733177817,"score_spread":0.2276950285549499,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}